Christopher Larson
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Metal complexes synthesis and properties
- CAR-T cell therapy research
- Nutrition and Dietetics top 2%
- Trace Elements in Health
Papers in
- Oncology 25
- CAR-T cell therapy research 10
- Drug Transport and Resistance Mechanisms 10
- Metal complexes synthesis and properties 6
- Lung Cancer Research Studies 3
-
- Trace Elements in Health 12
- Co-authors
- Stephen B. Howell (12 shared papers)Roohangiz Safaei (9 shared papers)Brian G. Blair (7 shared papers)Bryan T. Oronsky (19 shared papers)Tony R. Reid (11 shared papers)Arnold L. Oronsky (10 shared papers)Michael J. Sailor (1 shared paper)Michelle Lybeck (3 shared papers)
- Journals
- Molecular Pharmacology (6 papers)Clinical Cancer Research (2 papers)Cancer Gene Therapy (2 papers)Future Oncology (2 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- United StatesSouth AfricaFinland
In The Last Decade
Christopher Larson
36 papers receiving 1.8k citations
Christopher Larson's Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 867
- Nutrition and Dietetics 451
- Neurology 191
- Library and Information Sciences 13
- Biotechnology 73
Countries citing papers authored by Christopher Larson
This map shows the geographic impact of Christopher Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Larson more than expected).
Fields of papers citing papers by Christopher Larson
This network shows the impact of papers produced by Christopher Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Larson. The network helps show where Christopher Larson may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Larson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Review of Persistent Post-COVID Syndrome (PPCS) Hit paper breakdown → | 2021 | 299 |
| 2 | 2010 | 295 | |
| 3 | 2020 | 171 | |
| 4 | 2008 | 150 | |
| 5 | 2009 | 128 | |
| 6 | 2015 | 113 | |
| 7 | 2008 | 81 | |
| 8 | 2009 | 80 | |
| 9 | 2010 | 59 | |
| 10 | 2010 | 54 | |
| 11 | 2019 | 47 | |
| 12 | 2010 | 47 | |
| 13 | 2012 | 44 | |
| 14 | 2010 | 34 | |
| 15 | 2021 | 32 | |
| 16 | 2014 | 30 | |
| 17 | 2017 | 20 | |
| 18 | 2014 | 19 | |
| 19 | 2022 | 15 | |
| 20 | 2022 | 14 |
About Christopher Larson
Christopher Larson is a scholar working on Oncology, Nutrition and Dietetics, Biotechnology, Genetics and Molecular Biology, having authored 36 papers that have together received 1.9k indexed citations. Recurring topics across this work include Trace Elements in Health (12 papers), Virus-based gene therapy research (11 papers), CAR-T cell therapy research (10 papers), Drug Transport and Resistance Mechanisms (10 papers), Cancer Research and Treatments (6 papers), Metal complexes synthesis and properties (6 papers), RNA Interference and Gene Delivery (4 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (867 citations), Nutrition and Dietetics (451 citations), Neurology (191 citations), Library and Information Sciences (13 citations) and Biotechnology (73 citations). Christopher Larson has collaborated with scholars based in United States, South Africa and Finland. Frequent co-authors include Stephen B. Howell, Roohangiz Safaei, Brian G. Blair, Bryan T. Oronsky, Tony R. Reid, Arnold L. Oronsky, Michael J. Sailor, Michelle Lybeck, Santosh Kesari and Terese Hammond. Their work appears in journals such as Molecular Pharmacology, Clinical Cancer Research, Cancer Gene Therapy, Future Oncology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.